September 28, 2016 7:34 PM ET

Pharmaceuticals

Company Overview of Thios Pharmaceuticals, Inc.

Executive Profile

Bruce A. Hironaka J.D., MBA

Chief Executive Officer, President and Director, Thios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
59--

Background

Mr. Bruce A. Hironaka, JD, MBA has been Founding Chief Executive Officer of Agenovir Corporation since October 2014. Mr. Hironaka has 25 years of executive-level company-building, corporate development, operational and strategic experience in the life science industry. He served as the President and Chief Executive Officer of Thios Pharmaceuticals, Inc. Prior to Agenovir, he served in executive roles with several start-up and early-stage life science companies including ...

Corporate Headquarters

951 Cerrito Street
Albany, California 94706

United States

Phone: 510-420-6700
Fax: 510-420-6790

Board Members Memberships

Chief Executive Officer, President and Director
President, Chief Executive Officer, and Director
Founding Chief Executive Officer and Director

Education

BA
University of California Berkeley
JD
Stanford University
MBA
Stanford University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Thios Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.